{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:38:36Z","timestamp":1789663116181,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Gutenberg-University Mainz","award":["S"],"award-info":[{"award-number":["S"]}]},{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prompt reperfusion is important to rescue ischemic tissue; however, the process itself presents a key pathomechanism that contributes to a poor outcome following cardiac arrest. Experimental data have suggested the use of levosimendan to limit ischemia\u2013reperfusion injury by improving cerebral microcirculation. However, recent studies have questioned this effect. The present study aimed to investigate the influence on hemodynamic parameters, cerebral perfusion and oxygenation following cardiac arrest by ventricular fibrillation in juvenile male pigs. Following the return of spontaneous circulation (ROSC), animals were randomly assigned to levosimendan (12\u00a0\u00b5g\/kg, followed by 0.3\u00a0\u00b5g\/kg\/min) or vehicle treatment for 6\u00a0h. Levosimendan-treated animals showed significantly higher brain PbtO\n                    <jats:sub>2<\/jats:sub>\n                    levels. This effect was not accompanied by changes in cardiac output, preload and afterload, arterial blood pressure, or cerebral microcirculation indicating a local effect. Cerebral oxygenation is key to minimizing damage, and thus, current concepts are aimed at improving impaired cardiac output or cerebral perfusion. In the present study, we showed that NIRS does not reliably detect low PbtO\n                    <jats:sub>2<\/jats:sub>\n                    levels and that levosimendan increases brain oxygen content. Thus, levosimendan may present a promising therapeutic approach to rescue brain tissue at risk following cardiac arrest or ischemic events such as stroke or traumatic brain injury.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-93621-x","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T06:02:44Z","timestamp":1625810564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Levosimendan increases brain tissue oxygen levels after cardiopulmonary resuscitation independent of cardiac function and cerebral perfusion"],"prefix":"10.1038","volume":"11","author":[{"given":"Andreas","family":"Garc\u00eda-Bardon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kamuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ziebart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"D\u00fcnges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Morsbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge C.","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"93621_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003969","author":"DC Ashana","year":"2019","unstructured":"Ashana, D. C. et al. Determining the association between end-of-life care resources and patient outcomes in Pennsylvania ICUs. Crit. Care Med. https:\/\/doi.org\/10.1097\/CCM.0000000000003969 (2019).","journal-title":"Crit. Care Med."},{"key":"93621_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejheart.2006.06.001","volume":"9","author":"R Berger","year":"2007","unstructured":"Berger, R. et al. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure. Eur. J. Heart Fail. 9, 202\u2013208. https:\/\/doi.org\/10.1016\/j.ejheart.2006.06.001 (2007).","journal-title":"Eur. J. Heart Fail."},{"key":"93621_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/j.1399-6576.2007.01383.x","volume":"51","author":"E Koudouna","year":"2007","unstructured":"Koudouna, E. et al. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Acta Anaesthesiol. Scand. 51, 1123\u20131129. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01383.x (2007).","journal-title":"Acta Anaesthesiol. Scand."},{"key":"93621_CR4","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1097\/CCM.0000000000000308","volume":"42","author":"RF Kelm","year":"2014","unstructured":"Kelm, R. F. et al. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats. Crit. Care Med. 42, e410-419. https:\/\/doi.org\/10.1097\/CCM.0000000000000308 (2014).","journal-title":"Crit. Care Med."},{"key":"93621_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073758","volume":"8","author":"P Onody","year":"2013","unstructured":"Onody, P. et al. Levosimendan: A cardiovascular drug to prevent liver ischemia-reperfusion injury?. PLoS ONE 8, e73758. https:\/\/doi.org\/10.1371\/journal.pone.0073758 (2013).","journal-title":"PLoS ONE"},{"key":"93621_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","volume":"159","author":"Z Papp","year":"2012","unstructured":"Papp, Z. et al. Levosimendan: Molecular mechanisms and clinical implications: Consensus of experts on the mechanisms of action of levosimendan. Int. J. Cardiol. 159, 82\u201387. https:\/\/doi.org\/10.1016\/j.ijcard.2011.07.022 (2012).","journal-title":"Int. J. Cardiol."},{"key":"93621_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2377-10-97","volume":"10","author":"AB Roehl","year":"2010","unstructured":"Roehl, A. B. et al. Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury. BMC Neurol. 10, 97. https:\/\/doi.org\/10.1186\/1471-2377-10-97 (2010).","journal-title":"BMC Neurol."},{"key":"93621_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000121394","volume":"41","author":"B Lafci","year":"2008","unstructured":"Lafci, B. et al. Protection of the spinal cord from ischemia: Comparative effects of levosimendan and iloprost. Eur. Surg. Res. 41, 1\u20137. https:\/\/doi.org\/10.1159\/000121394 (2008).","journal-title":"Eur. Surg. Res."},{"key":"93621_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/bja\/aes376","volume":"110","author":"KU Klein","year":"2013","unstructured":"Klein, K. U. et al. Transmission of arterial oxygen partial pressure oscillations to the cerebral microcirculation in a porcine model of acute lung injury caused by cyclic recruitment and derecruitment. Br. J. Anaesth. 110, 266\u2013273. https:\/\/doi.org\/10.1093\/bja\/aes376 (2013).","journal-title":"Br. J. Anaesth."},{"key":"93621_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ienj.2009.01.001","volume":"17","author":"JP Nolan","year":"2009","unstructured":"Nolan, J. P. et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part 1). Int. Emerg. Nurs. 17, 203\u2013225. https:\/\/doi.org\/10.1016\/j.ienj.2009.01.001 (2009).","journal-title":"Int. Emerg. Nurs."},{"key":"93621_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ejphar.2014.06.024","volume":"740","author":"G Varvarousi","year":"2014","unstructured":"Varvarousi, G., Stefaniotou, A., Varvaroussis, D., Aroni, F. & Xanthos, T. The role of Levosimendan in cardiopulmonary resuscitation. Eur. J. Pharmacol. 740, 596\u2013602. https:\/\/doi.org\/10.1016\/j.ejphar.2014.06.024 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"93621_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12871-017-0309-3","volume":"17","author":"B Wu","year":"2017","unstructured":"Wu, B. et al. Supplement of levosimendan to epinephrine improves initial resuscitation outcomes from asphyxial cardiac arrest. BMC Anesthesiol. 17, 18. https:\/\/doi.org\/10.1186\/s12871-017-0309-3 (2017).","journal-title":"BMC Anesthesiol."},{"key":"93621_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.CCM.0000156241.55872.15","volume":"33","author":"L Huang","year":"2005","unstructured":"Huang, L., Weil, M. H., Tang, W., Sun, S. & Wang, J. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit. Care Med. 33, 487\u2013491 (2005).","journal-title":"Crit. Care Med."},{"key":"93621_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1124\/jpet.112.193961","volume":"342","author":"E Grossini","year":"2012","unstructured":"Grossini, E. et al. Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs. J. Pharmacol. Exp. Ther. 342, 376\u2013388. https:\/\/doi.org\/10.1124\/jpet.112.193961 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"93621_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016139","volume":"9","author":"CH Wang","year":"2020","unstructured":"Wang, C. H., Chang, W. T., Tsai, M. S., Huang, C. H. & Chen, W. J. Synergistic effects of moderate therapeutic hypothermia and levosimendan on cardiac function and survival after asphyxia-induced cardiac arrest in rats. J. Am. Heart Assoc. 9, e016139. https:\/\/doi.org\/10.1161\/JAHA.120.016139 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"93621_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1097\/00003246-200111000-00022","volume":"29","author":"A Oldner","year":"2001","unstructured":"Oldner, A. et al. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit. Care Med. 29, 2185\u20132193 (2001).","journal-title":"Crit. Care Med."},{"key":"93621_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2377-13-106","volume":"13","author":"M Hein","year":"2013","unstructured":"Hein, M. et al. Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model. BMC Neurol. 13, 106. https:\/\/doi.org\/10.1186\/1471-2377-13-106 (2013).","journal-title":"BMC Neurol."},{"key":"93621_CR18","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/CCM.0b013e31817cede9","volume":"36","author":"M Fries","year":"2008","unstructured":"Fries, M. et al. Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit. Care Med. 36, 1886\u20131891. https:\/\/doi.org\/10.1097\/CCM.0b013e31817cede9 (2008).","journal-title":"Crit. Care Med."},{"key":"93621_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/ANA.0b013e31822cf893","volume":"23","author":"KU Klein","year":"2011","unstructured":"Klein, K. U. et al. A novel technique for monitoring of fast variations in brain oxygen tension using an uncoated fluorescence quenching probe (Foxy AL-300). J. Neurosurg. Anesthesiol. 23, 341\u2013346. https:\/\/doi.org\/10.1097\/ANA.0b013e31822cf893 (2011).","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"93621_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/ANA.0b013e3181bea439","volume":"22","author":"KU Klein","year":"2010","unstructured":"Klein, K. U. et al. Intraoperative monitoring of cerebral microcirculation and oxygenation\u2014A feasibility study using a novel photo-spectrometric laser-Doppler flowmetry. J. Neurosurg. Anesthesiol. 22, 38\u201345. https:\/\/doi.org\/10.1097\/ANA.0b013e3181bea439 (2010).","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"93621_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0014-2999(01)01350-4","volume":"428","author":"DM Kopustinskiene","year":"2001","unstructured":"Kopustinskiene, D. M., Pollesello, P. & Saris, N. E. Levosimendan is a mitochondrial K(ATP) channel opener. Eur. J. Pharmacol. 428, 311\u2013314 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"93621_CR22","doi-asserted-by":"publisher","unstructured":"Sommer, S. et al. Impact of levosimendan and ischaemia-reperfusion injury on myocardial subsarcolemmal mitochondrial respiratory chain, mitochondrial membrane potential, Ca2+ cycling and ATP synthesis. Eur. J. Cardiothorac. Surg. 49, e54\u201362; discussion e62. https:\/\/doi.org\/10.1093\/ejcts\/ezv397 (2016).","DOI":"10.1093\/ejcts\/ezv397"},{"key":"93621_CR23","doi-asserted-by":"crossref","unstructured":"Rudolph, A. M. & Heymann, M. A. The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow. Circ. Res. 21, 163\u2013184 (1967).","DOI":"10.1161\/01.RES.21.2.163"},{"key":"93621_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jchromb.2017.11.012","volume":"1072","author":"S Morsbach","year":"2018","unstructured":"Morsbach, S. et al. Quantification of fluorescent dyes in organ tissue samples via HPLC analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1072, 34\u201339. https:\/\/doi.org\/10.1016\/j.jchromb.2017.11.012 (2018).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93621-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:17:00Z","timestamp":1670048220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["93621"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-93621-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14220"}}